Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Muirhead

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Lupus|May 6, 2015
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLEH Cohen, C J Doré, S Clawson, et al.
American Journal of Nephrology|January 1, 1986
Zinc metabolism in patients on maintenance hemodialysisN Muirhead, A Kertesz, P R Flanagan, et al.
Nephron|January 1, 1996
Effect of anaemia correction on skeletal muscle metabolism in patients with end-stage renal disease: 31P magnetic resonance spectroscopy assessmentR T Thompson, N Muirhead, G D Marsh, et al.
Transplantation|August 1, 1981
Plasma exchange in acute renal allograft rejection: is a controlled trial really necessary?D Power, A Nicholls, N Muirhead, et al.
British Journal of Urology|June 1, 1982
Loin pain and haematuria in young women: diagnostic pitfallsA J Nicholls, N Muirhead, N Edward, et al.
The Quarterly Journal of Medicine|January 1, 1982
Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophyN Muirhead, S Adami, L M Sandler, et al.
American Journal of Nephrology|January 1, 1992
Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid diseaseN Muirhead, D N Churchill, M Goldstein, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophyN Muirhead, G R Catto, N Edward, et al.
Cephalalgia : an International Journal of Headache|June 17, 2003
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptanM Färkkilä, J Olesen, C Dahlöf, et al.
Clinical Nephrology|March 1, 1995
Effect of recombinant human erythropoietin on hospitalization of hemodialysis patientsD N Churchill, N Muirhead, M Goldstein, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Lupus|May 6, 2015
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLEH Cohen, C J Doré, S Clawson, et al.
American Journal of Nephrology|January 1, 1986
Zinc metabolism in patients on maintenance hemodialysisN Muirhead, A Kertesz, P R Flanagan, et al.
Nephron|January 1, 1996
Effect of anaemia correction on skeletal muscle metabolism in patients with end-stage renal disease: 31P magnetic resonance spectroscopy assessmentR T Thompson, N Muirhead, G D Marsh, et al.
Transplantation|August 1, 1981
Plasma exchange in acute renal allograft rejection: is a controlled trial really necessary?D Power, A Nicholls, N Muirhead, et al.
British Journal of Urology|June 1, 1982
Loin pain and haematuria in young women: diagnostic pitfallsA J Nicholls, N Muirhead, N Edward, et al.
The Quarterly Journal of Medicine|January 1, 1982
Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophyN Muirhead, S Adami, L M Sandler, et al.
American Journal of Nephrology|January 1, 1992
Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid diseaseN Muirhead, D N Churchill, M Goldstein, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophyN Muirhead, G R Catto, N Edward, et al.
Cephalalgia : an International Journal of Headache|June 17, 2003
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptanM Färkkilä, J Olesen, C Dahlöf, et al.
Clinical Nephrology|March 1, 1995
Effect of recombinant human erythropoietin on hospitalization of hemodialysis patientsD N Churchill, N Muirhead, M Goldstein, et al.
Pageof 9